期刊文献+

氯沙坦通过增加葡萄糖转运蛋白4膜转位改善2型糖尿病大鼠胰岛素抵抗 被引量:2

Insulin resistance is improved by Iosartan in type 2 diabetic rats through glucose transporter protein4 pathway
原文传递
导出
摘要 目的研究2型糖尿病(T2DM)sD大鼠血管紧张素Ⅱ受体拮抗剂(ARB)是否改善胰岛素抵抗及对IRSl磷酸化、P13K途径中Akt磷酸化及GLUT4转位的影响。方法42只sD大鼠分别给予高脂高糖饮食/链脲佐菌素(STZ)或普通饮食喂养,当空腹血糖(FPG)〉/7.8mmol/L且伴有胰岛素抵抗者为成模T2DM大鼠20只,正常组20只;分为正常不干预组(A组)、正常干预组(B组)、T2DM不干预组(C组)及T2DM干预组(D组),每组10只。B组及D组给予氯沙坦(4mg·k~·d“),干预6周后计算胰岛素敏感指数(ISI),取腓肠肌备用。通过免疫组织化学(IHC)及Westernbloting检测IRSl/P'yr_IRSl、Akt/Pser473-Akt及GLUT4蛋白表达。结果(1)成功制备了T2DM大鼠模型。IHC结果示C、D组较A、B组P”-IRSl、P-Akt蛋白表达减少;Westernbloting结果示Ptyr。-IRSl、GLUT4膜蛋白表达减少(P〈0.05)。(2)氯沙坦干预后,D组FBG(mmol/L)、FINS(p^U/M1)(18.8±4.1,27±5)较c组(19.74-3.7,27±6)降低,IsI升高(D组一6.18±0.08,C组一6.18±0.08,P〈0.05);IHC示Ptyr-IRSl蛋白表达升高(P〈0.05);Westernbloting示GLUT4膜蛋白、P-IRSl上升(P〈0.05),P-Akt蛋白的表达无差异(P〉0.05)。结论氯沙坦通过增加骨骼肌组织中GLUT4的转位而改善T2DM大鼠的胰岛素抵抗。 Objective An animal model for type 2 diabetes mellitus (T2DM) was developed for studying improvment of anigotensin II receptor blocker on insulin resistance (IR) and influence on insulin receptor substrate 1 (IRS1)and Akt phosphorylation of phosphatidylinositol 3-kinase (PI3K)pathway and translocatiou of glucose transporter-4 ( GLUT4 ). Methods Twenty of 42 male SD rats were randomly fed with high-fat/high-sugar diet and treated with Streptozotozin for type 2 diabetic model and other 20 for nol^nal control group fed with standard diet. Rats with FPG~〉7.8 mmol/L accompanied by IR were considered as T2DM models. Rats were randomly divided into control group A, control treated group B, T2DM control group C and T2DM treated group D(n = 10 in each group) , rats in group B and D were treated with losartan. Six weeks later, blood samples were measured to calculate ISI( insulin-sensitivity index). Skeletal muscles were removed from hind legs and stored. Expressions of IRS1/Ptyr-IRS1, Akt/P^47S-Akt and GLUT4 protein detected by Immunohistochemistry (IHC) and Western bloting. Results ( i ) Models of T2DM rats were successfully induced. Compared with group A and B, expressions of Ptyr-IRS1, p^rav3_Akt in group C and D by IHC and expressions of PtYr-IRS1 and membrane GLUT4 by Western bloting reduced significantly ( P 〈 0. 05). (2)The value of FPG (retool/L) , FINS (p,U/M1) of T2DM rats decreased in Group D (18.8 + 4. 1, 27 _+5)compared with group C(19.7 +3.7,27 -+6) , while ISI increased(D group -6. 18 -+0. 08, C group -6. 18 -+0. 08, P 〈0. 05), the expression of P^Yr-IRS1 increased(P 〈0. 05) (IHC), expression of membrane GLUT4 and p'yr-IRS1 increased( P 〈0. 05 )( Western bloting) , there was no difference of p^r473_Akt expression in both ways. Conclusion Losartan can increase the translocation of GLUT4 in muscle tissues to improve IR status of T2DM rats.
出处 《中华糖尿病杂志》 CAS CSCD 2014年第1期42-45,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
基金 教育部春晖计划(Z2007.1-01008) 内蒙古医科大学附属医院重大科研项目(NYFYZD201005)
关键词 2型糖尿病大鼠 氯沙坦 葡萄糖转运蛋白4 胰岛素抵抗 Type 2 diabetic rats Losartan Glucose transporter 4 Insulin resistance
  • 相关文献

参考文献3

二级参考文献73

  • 1Negis Y,Aytan N,Ozer N,et al. The effect of tocopherylphos- phates on atherosclerosis progression in rabbits fed with a higheholesterol diet[J]. Arch Physiol Biochem,2006(450) :63- 66.
  • 2Buteau J,EI-Assaad W, Rhodes C J, et al. Glucagon-like pep- tide-1 prevents beta cell glueolipotoxicity[J]. Diabetes, 2008, 57:1205-1215.
  • 3Iyer SN, Katovich MJ. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Am J Hypertens 1996; 9:662-668.
  • 4Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462-1470.
  • 5Dombrowski L, Roy D, Marcotte B, Marette A. A new procedure for the isolation of plasma membranes: T tubules, and internal membranes from skeletal muscle. Am J Physiol 1996; 270:E667-E676.
  • 6Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG,Gadbois TM, Reaven GM. A new rat model of type 2 diabetes:the fat-fed, streptozotocin-treated rat. Metabolism 2000; 49:1390-1396.
  • 7Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000; 108 Suppl 6a:2S-8S.
  • 8Proietto J, Filippis A, Nakhla C et al. Nutrient-induced insulin resistance. Mol Cell Endocrinol 1999; 151(1-2):143.
  • 9Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:1988-1992.
  • 10Warram JH, Martin BC, Krowleski AS et al. Slow glucose removal rate and hyperinsulinemia precede the development of type Ⅱ diabetes in the offspring of diabetic patients. Ann Intern Med 1990; 113:909-915.

共引文献31

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部